| Literature DB >> 27258414 |
Eleanor K Pickett1, Robert M Koffie2, Susanne Wegmann2, Christopher M Henstridge1, Abigail G Herrmann1, Marti Colom-Cadena3, Alberto Lleo3, Kevin R Kay2, Melissa Vaught2, Roy Soberman2, Dominic M Walsh4, Bradley T Hyman2, Tara L Spires-Jones1.
Abstract
Alzheimer's disease (AD) is characterized by memory loss, insidious cognitive decline, profound neurodegeneration, and the extracellular accumulation of amyloid-β (Aβ) peptide in senile plaques and intracellular accumulation of tau in neurofibrillary tangles. Loss and dysfunction of synapses are believed to underlie the devastating cognitive decline in AD. A large amount of evidence suggests that oligomeric forms of Aβ associated with senile plaques are toxic to synapses, but the precise sub-synaptic localization of Aβ and which forms are synaptotoxic remain unknown. Here, we characterize the sub-synaptic localization of Aβ oligomers using three high-resolution imaging techniques, stochastic optical reconstruction microscopy, immunogold electron microscopy, and Förster resonance energy transfer in a plaque-bearing mouse model of AD. With all three techniques, we observe oligomeric Aβ inside synaptic terminals. Further, we tested a panel of Aβ antibodies using the relatively high-throughput array tomography technique to determine which forms are present in synapses. Our results show that different oligomeric Aβ species are present in synapses and highlight the potential of array tomography for rapid testing of aggregation state specific Aβ antibodies in brain tissue.Entities:
Keywords: Alzheimer’s disease; amyloid-β; array tomography; synapses
Mesh:
Substances:
Year: 2016 PMID: 27258414 DOI: 10.3233/JAD-160007
Source DB: PubMed Journal: J Alzheimers Dis ISSN: 1387-2877 Impact factor: 4.472